AAAAAA

   
Results: 1-13 |
Results: 13
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance
Authors: Rasmussen, T Fink-Jensen, A Sauerberg, P Swedberg, MDB Thomsen, C Sheardown, MJ Jeppesen, L Calligaro, DO DeLapp, NW Whitesitt, C Ward, JS Shannon, HE Bymaster, FP
Citation: T. Rasmussen et al., The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance, SCHIZOPHR R, 49(1-2), 2001, pp. 193-201
The muscarinic receptor agonist xanomeline has an anti psychotic-like profile in the rat
Authors: Stanhope, KJ Mirza, NR Bickerdike, MJ Bright, JL Harrington, NR Hesselink, MB Kennett, GA Lightowler, S Sheardown, MJ Syed, R Upton, RL Wadsworth, G Weiss, SM Wyatt, A
Citation: Kj. Stanhope et al., The muscarinic receptor agonist xanomeline has an anti psychotic-like profile in the rat, J PHARM EXP, 299(2), 2001, pp. 782-792
Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells
Authors: Porter, RHP Malcolm, CS Allen, NH Lamb, H Revell, DF Sheardown, MJ
Citation: Rhp. Porter et al., Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells, BIOCH PHARM, 62(4), 2001, pp. 431-438
Xanomeline, an M-1/M-4 preferring muscarinic cholinergic receptor agonist,produces antipsychotic-like activity in rats and mice
Authors: Shannon, HE Rasmussen, K Bymaster, FP Hart, JC Peters, SC Swedberg, MDB Jeppesen, L Sheardown, MJ Sauerberg, P Fink-Jensen, A
Citation: He. Shannon et al., Xanomeline, an M-1/M-4 preferring muscarinic cholinergic receptor agonist,produces antipsychotic-like activity in rats and mice, SCHIZOPHR R, 42(3), 2000, pp. 249-259
Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice
Authors: Rasmussen, T Sauerberg, P Nielsen, EB Swedberg, MDB Thomsen, C Sheardown, MJ Jeppesen, L Calligaro, DO DeLapp, NW Whitesitt, C Ward, JS Shannon, HE Bymaster, FP Fink-Jensen, A
Citation: T. Rasmussen et al., Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice, EUR J PHARM, 402(3), 2000, pp. 241-246
Modulation of gamma-aminobutyric acid responses in the rat optic nerve
Authors: Empson, RM Sheardown, MJ Newberry, NR
Citation: Rm. Empson et al., Modulation of gamma-aminobutyric acid responses in the rat optic nerve, EUR J PHARM, 401(3), 2000, pp. 339-342
Chlormethiazole inhibits epileptiform activity by potentiating GABA(A) receptor function
Authors: Empson, RM Gee, VJ Sheardown, MJ Newberry, NR
Citation: Rm. Empson et al., Chlormethiazole inhibits epileptiform activity by potentiating GABA(A) receptor function, BRAIN RES, 884(1-2), 2000, pp. 31-34
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats
Authors: Shannon, HE Hart, JC Bymaster, FP Calligaro, DO Delapp, NW Mitch, CH Ward, JS Fink-Jensen, A Sauerberg, P Jeppesen, L Sheardown, MJ Swedberg, MDB
Citation: He. Shannon et al., Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats, J PHARM EXP, 290(2), 1999, pp. 901-907
N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects
Authors: Knutsen, LJS Lau, J Petersen, H Thomsen, C Weis, JU Shalmi, M Judge, ME Hansen, AJ Sheardown, MJ
Citation: Ljs. Knutsen et al., N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects, J MED CHEM, 42(18), 1999, pp. 3463-3477
1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives
Authors: Jeppesen, L Olesen, PH Hansen, L Sheardown, MJ Thomsen, C Rasmussen, T Jensen, AF Christensen, MS Rimvall, K Ward, JS Whitesitt, C Calligaro, DO Bymaster, FP Delapp, NW Felder, CC Shannon, HE Sauerberg, P
Citation: L. Jeppesen et al., 1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives, J MED CHEM, 42(11), 1999, pp. 1999-2006
Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells
Authors: Porter, RHP Benwell, KR Lamb, H Malcolm, CS Allen, NH Revell, DF Adams, DR Sheardown, MJ
Citation: Rhp. Porter et al., Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells, BR J PHARM, 128(1), 1999, pp. 13-20
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats
Authors: Fink-Jensen, A Kristensen, P Shannon, HE Calligaro, DO Delapp, NW Whitesitt, C Ward, JS Thomsen, C Rasmusseen, T Sheardown, MJ Jeppesen, L Sauerberg, P Bymaster, FP
Citation: A. Fink-jensen et al., Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats, NEUROREPORT, 9(15), 1998, pp. 3481-3486
Adenosine A(1) and A(3) selective N-alkoxypurines as novel cytokine modulators and neuroprotectants
Authors: Knutsen, LJS Sheardown, MJ Roberts, SM Mogensen, JP Olsen, UB Thomsen, C Bowler, AN
Citation: Ljs. Knutsen et al., Adenosine A(1) and A(3) selective N-alkoxypurines as novel cytokine modulators and neuroprotectants, DRUG DEV R, 45(3-4), 1998, pp. 214-221
Risultati: 1-13 |